Bruce Huebner
…But now James Burns has been replaced at Vermillion, staying on the Board but handing over his reigns as Chairman to Bruce Huebner.
Huebner is part of the company's leadership succession plan and recently served as interim CEO before Thomas McLain was appointed.
Huebner has over 37 years of experience in multiple clinical diagnostic companies, including Osmetech Molecular Diagnostics, Nanogen and Gen-Probe.
James Burns said: “I look forward to working closely with Bruce and our new president to build shareholder value, as we advance Vermillion as a leading diagnostics company addressing unmet clinical needs in women's health.”